https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-25 / Phytother Res 2021 Oct;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-25 / Phytother Res 2021 Oct;2021-10-25 00:00:002021-10-25 00:00:00Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-16 / Eur J Cancer 2021 Oct;158:123-132
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-16 / Eur J Cancer 2021 Oct;158:123-1322021-10-16 00:00:002021-10-16 00:00:00Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-14 / Biomedicines 2021 Oct;9(10)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-14 / Biomedicines 2021 Oct;9(10)2021-10-14 00:00:002021-10-14 00:00:00Antitumoral Activities of Curcumin and Recent Advances to ImProve Its Oral Bioavailability
https://www.iozk.de/wp-content/uploads/2021/10/PrimoMedico.jpg
454
1400
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2021-10-13 14:19:262021-10-13 14:39:09Primo Medico Fachärzte Talk: Dr. Stücker im Interview
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-09 / Life Sci 2021 Dec;286:120043
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-09 / Life Sci 2021 Dec;286:1200432021-10-09 00:00:002023-01-31 16:07:46Curcuma as an adjuvant in colorectal cancer treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-05 / Front Immunol 2021;12:721830
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-05 / Front Immunol 2021;12:7218302021-10-05 00:00:002022-01-10 09:06:12Oncolytic Viro-Immunotherapy: An Emerging Option in the Treatment of Gliomas
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-74
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2021-10-04 / Gene Ther 2023 Feb;30(1-2):64-742021-10-04 00:00:002023-05-30 16:42:19Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy
